Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInt.biotech. Regulatory News (IBT)

Share Price Information for Int.biotech. (IBT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 644.00
Bid: 652.00
Ask: 658.00
Change: -4.00 (-0.62%)
Spread: 6.00 (0.92%)
Open: 658.00
High: 666.00
Low: 644.00
Prev. Close: 648.00
IBT Live PriceLast checked at -
International Biotechnology is an Investment Trust

To achieve capital growth through investing in high growth, development stage biotechnology companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Kepler Trust Intelligence: New Research

20 May 2021 08:57

RNS Number : 2805Z
Intl. Biotechnology Trust PLC
20 May 2021
 

International Biotechnology: New research

20/05/2021

IBT has had a change of management - but no change of strategy…

The investment companies team at Kepler Trust Intelligence has produced a new piece of investment bank quality research about the trust, designed to provide a clear and comprehensive reference for long term investors. This note is free to read for UK investors.

Click here to read the note in full

 

Visit http://www.trustintelligence.co.uk/investor for more high quality independent investment trust research.

 

Important information

This report has been issued by Kepler Partners LLP. The analyst who has prepared this report is aware that Kepler Partners LLP has a relationship with the company covered in this report and/or a conflict of interest which may impair the objectivity of the research.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that if you are a private investor independent financial advice should be taken before making any investment or financial decision.

Kepler Partners is not authorised to make recommendations to retail clients. This report has been issued by Kepler Partners LLP, is based on factual information only, is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.

The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's Conflict of Interest policy is available on request.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 9/10 Savile Row, London W1S 3PF with registered number OC334771.

Visit http://www.trustintelligence.co.uk/investor for more high quality independent investment trust research.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEAXSEASLFEEA
Date   Source Headline
1st Nov 202211:26 amRNSTotal Voting Rights
1st Nov 20227:00 amRNSAnnual Financial Report
31st Oct 20225:20 pmRNSTransaction in Own Shares
27th Oct 20225:33 pmRNSTransaction in Own Shares
26th Oct 20224:39 pmRNSTransaction in Own Shares
25th Oct 20228:00 amRNSPortfolio Update
24th Oct 20225:12 pmRNSTransaction in Own Shares
18th Oct 20225:36 pmRNSTransaction in Own Shares
17th Oct 20221:16 pmRNSTransaction in Own Shares
13th Oct 20225:55 pmRNSTransaction in Own Shares
13th Oct 20227:00 amRNSKepler Trust Intelligence: New Research
3rd Oct 202212:07 pmRNSTotal Voting Rights
30th Sep 20227:00 amRNSCompliance with the Market Abuse Regulation
20th Sep 20225:22 pmRNSTransaction in Own Shares
20th Sep 20228:00 amRNSPortfolio Update
25th Aug 20228:30 amRNSPortfolio Update
1st Aug 202211:12 amRNSTotal Voting Rights
22nd Jul 20223:29 pmRNSDividend Declaration
20th Jul 20229:00 amRNSPortfolio Update
11th Jul 20221:26 pmRNSReplacement: Transaction in Own Shares
7th Jul 20225:45 pmRNSTransaction in Own Shares
6th Jul 20225:16 pmRNSTransaction in Own Shares
1st Jul 20225:40 pmRNSTransaction in Own Shares
1st Jul 20222:37 pmRNSBlock listing Interim Review
30th Jun 20227:15 amEQSHardman & Co Research: International Biotechnology Trust (IBT) - M&A activity on the rise
21st Jun 202210:30 amRNSPortfolio Update
1st Jun 202211:53 amPRNNet Asset Value(s)
1st Jun 202210:14 amRNSTotal Voting Rights
31st May 202210:53 amPRNNet Asset Value(s)
30th May 202211:35 amPRNNet Asset Value(s)
27th May 202210:46 amPRNNet Asset Value(s)
26th May 202210:05 amPRNNet Asset Value(s)
25th May 202211:31 amPRNNet Asset Value(s)
24th May 202210:24 amPRNNet Asset Value(s)
23rd May 202211:23 amPRNNet Asset Value(s)
18th May 20227:00 amRNSPortfolio Update
11th May 20226:09 pmRNSDirector/PDMR Shareholding
11th May 20224:47 pmRNSPortfolio Update
6th May 202211:00 amRNSCorrection: Half-year Report
4th May 20227:00 amRNSHalf-year Report
3rd May 20223:16 pmRNSTotal Voting Rights
21st Apr 20227:00 amRNSPortfolio Update
14th Apr 202210:30 amPRNNet Asset Value(s)
13th Apr 202211:18 amPRNNet Asset Value(s)
12th Apr 202210:43 amPRNNet Asset Value(s)
11th Apr 20225:32 pmRNSTransaction in Own Shares
11th Apr 202210:50 amPRNNet Asset Value(s)
8th Apr 202211:13 amPRNNet Asset Value(s)
7th Apr 202211:15 amPRNNet Asset Value(s)
6th Apr 20225:07 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.